CLINICAL_TRIALS
trial_result
· 2010-11-18
Clinical Trial Update: A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine [Phase 3]
Summary
A Phase 3 trial comparing sunitinib and capecitabine in breast cancer was terminated. Results from the study were posted in November 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Breast Neoplasms | Phase 3 | Status: TERMINATED | Results posted: 2010-11-18